A. di Gaeta, A.A. Diano, P. Vassallo, E. Capobianco, M. Muto Neuroradiology unit A.O.R.N. “A. CARDARELLI” - Napoli Single voxel spectroscopy in the follow-up.

Slides:



Advertisements
Similar presentations
THE NEUROLOGICAL COMPLICATIONS OF THE RADIOTHERAPY: ASPECTS IN IMAGING
Advertisements

Imaging modalities in prostate cancer
Usefulness of the multimodality imaging for the diagnosis of an atypical lymphoma of the brainstem ATTIA M, KOUKI S, LANDOULSI M,BOUGUERRA S,AROUS Y, BOUJEMAA.
Assistant Lecturer Of Neurosurgery, Alexandria, Egypt Alex Neuro 2014.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Methods to Differentiate Radiation Induced Necrosis and Recurrent Disease in Gliomas Lars Ewell University of Arizona Medical Center Department of Radiation.
Bimonthly Meeting on Oct. 10, 2008 Metabolic Concentrations and Ratios of Brain Tissue Amarjeet Bhullar.
Voxel Location Dependence of Brain Metabolites as Determined by Magnetic Resonance Spectroscopy L.Ewell, A. Bhullar and B. Stea—Department of Radiation.
DW-MRI and MRS to Differentiate Radiation Necrosis and Recurrent Disease in Gliomas P100 Exams 4224, SV, 2x2x2cm MV Thomas Chong.
Multimodal Visualization for neurosurgical planning CMPS 261 June 8 th 2010 Uliana Popov.
Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence Manuel Gómez-Río & Antonio Rodríguez-Fernández.
Metabolic Concentrations and Ratios of Brain Tissue Amarjeet Bhullar, Lars Ewell, Tim McDaniel and Baldassarre Stea Department of Radiation Oncology, The.
Total Lesion Glycolysis by 18 F-FDG PET/CT a Reliable Predictor of Prognosis in Soft Tissue Sarcoma Ilkyu Han Musculoskeletal Tumor Center, Seoul National.
Case Study 24 Craig Horbinski, M.D., Ph.D.. You receive a consult case from an outside hospital on a brain biopsy from a 51 y/o male with a left sided.
Case Study 62 Kenneth Clark, MD. Question 1 This is a 32-year-old woman with progressive distortion of taste and smell. After seeing her primary care.
What can you see by MRI ? Stephen Paisey.
ACRIN ACRIN MRS data acquisition and Raw Data Handling Instructions – For GE Data.
Tumor Localization Techniques Richard Kao April 10, 2001 Computer Integrated Surgery II.
BRAINSTORM Understanding Diagnostic Scans: MRI, CT, PET AND MORE Stanley Lu, MD Director, Neuroradiology Monmouth Medical Center March 5, 2012.
Comparison of MRI Perfusion and PET-CT in Differentiating Brain Tumor Progression from Radiation Injury after Cranial Irradiation T. Jonathan Yang, M.D.
A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases.
Introduction Many clinicians routinely use multiple receive coils for magnetic resonance imaging (MRI) studies of the human brain. In conjunction with.
Case Study 50 Edward D. Plowey. Case History The patient is a 2 year old girl with normal birth and developmental histories who presented with new onset.
UPMC Pathology Resident Didactic Series March 31 & April 7, 2009 CNS NEOPLASMS Scott M. Kulich, MD, PhD VA Pittsburgh Healthcare System Assistant Professor.
In vivo MR Spectroscopy
Correlation and fusion of perfusion and spectroscopic MR imaging for the characterisation of brain tumors A. Förschler 1), K. Vester 1), G. Peters 2),
EVALUATION OF GLUTAMATE AND OTHER AMINO ACID LEVELS IN GLAUCOMA PATIENT WITH MR SPECTROSCOPY: PRELIMINARY STUDY Selim Doganay, MD¹; Cem Cankaya, MD¹; Alpay.
DW-MRI and MRS to Differentiate Radiation Necrosis and Recurrent Disease in Gliomas Protocol MRS data status 11/27/07 – 12/17/07 Thomas Chong.
Diagnostic Accuracy of Hyperacute MRI in Prediction of Residual Tumor and Progression in Pituitary Macroadenomas Abstract Id: IRIA – A Retrospective.
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC randomised trial From.
Abstract Id: IRIA INTRODUCTION  Spinal Schwannomas and Meningiomas are the most common intradural extramedullary lesion and account for 45% of.
S. Gaudino, V. Lorusso, M. Caulo *, A. Tartaro *, T. Tartaglione, G.M. Di Lella, C. Colosimo Dept. of Bio-imaging and Radiological Sciences, Policlinico.
A.Bocchio A.Bocchio Regional Hospital Valle d’Aosta, Italy Pilocytic juvenile astrocytoma: a difficult diagnosis?
Diffusely Infiltrating Gliomas with Non-Significant Contrast-Enhancement: Is 1 H-Magnetic Resonance Spectroscopy Chemical Shift Imaging a Clinically Reliable.
University of Michigan Department of Radiology Role of MR Spectroscopy in Differentiating Radiation Necrosis from Tumor Recurrence. Effects of radiation.
Metabolic mapping of human gliomas Assessment with simultaneous MR/PET imaging for preoperative „hot-spot“ imaging of suspected anaplastic gliomas S. Bisdas.
Magnetic Resonance Spectroscopy of the hippocampus Marton A 1, Bús L 2, Juhos V 3, Rudas G 2, Barsi P 2 1 University of Pécs, 2 SU MR Research Centre 3.
It is essential to obtain the exact history of the hypersalivation as well as a thorough and complete past medical history. Oral evaluation should be performed,
PROTON MAGNETIC RESONANCE SPECTROSCOPY OF THE CENTRAL NERVOUS SYSTEM Dr. Hazem Abu Zeid Yousef Lecturer of Diagnostic Radiology. Assiut University.
AUTOFLUORESCENCE AND 5-AMINOLEVULINIC ACID INDUCED FLUORESCENCE OF NORMAL BRAIN AND GLIOMA IN WISTAR RATS A.Čiburys, D.Gadonas, R.Gadonas, D.Kaškelytė,
In The Name of God. Multiple Sclerosis and Normal MRI new modalities for problems solving.
Date of download: 7/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Brain Damage After Coronary Artery Bypass Grafting.
Intratumoral topography of CNS gliomas revealed by diffusion tensor imaging: correlations with tumor volume and grade A. Jakab 1, P. Molnár 2, M. Emri.
Differentiation between Primary Central Nervous System Lymphoma and Glioblastoma on 3T-MR Imaging: Multivariate Analysis M. Kitajima 1, T. Hirai 1, Y.
Brain imaging prior to lung cancer resection
Diagnostic value of proton MR spectroscopy and diffusion-weighted MR imaging in childhood inherited neurometabolic brain diseases and review of the literature 
Magnetic Resonance Spectroscopy By A. Ghazavi, M.D.
3T MRI in paediatrics: Challenges and clinical applications
Radiotherapy treatment planning and long-term follow-up with [11C]methionine PET in patients with low-grade astrocytoma  Joanne Nuutinen, M.D., Pirkko.
1H MRS Characteristics of Cerebral alveolar echinococcosis
M.D. Patel, J. Zhang, G. Mazibrada, N. Davies, V. Sawlani
Gian Maria Busetto Sapienza Rome University
Neuroradiology Department Bellaria Hospital Bologna
with water suppression
In vivo MR Spectroscopy
The pathological diagnosis of diffuse gliomas: towards a smart synthesis of microscopic and molecular information in a multidisciplinary context  Pieter.
Volume 54, Issue 3, Pages (September 2008)
Pamela Garcia Pulido, James Neal, Shawn Halpin, Khalid Hamandi 
Preoperative brain injury in newborns with transposition of the great arteries  Steven P Miller, MD, Patrick S McQuillen, MD, Daniel B Vigneron, PhD, David.
MRI Brain Evaluation of brain diseases Stroke
Patient 1. Patient 1. Axial T2 FLAIR (A) MR image demonstrates abnormal T2 FLAIR signal in the right lateral pons extending into the right trigeminal nerve.
1H-MR-spectroscopy water-suppressed proton spectra of an 8-mL voxel located in the parietal region including predominantly normal-appearing white matter.
A 59-year-old woman with right superior frontal mass initially diagnosed as low-grade astrocytoma.A, Axial postcontrast T1-weighted image shows an ill-defined.
Fig. 4 DMI visualizes the Warburg effect in a patient with GBM after oral [6,6′-2H2]glucose intake. DMI visualizes the Warburg effect in a patient with.
Figure 2c.  Left parietal glioblastoma multiforme (WHO grade IV) in a 59-year-old woman. (a) Axial postcontrast T1-weighted MR image demonstrates a heterogeneously.
MR spectrum of a normal frontal lobe obtained at 1
Case 68. Case 68. Unspecific benign pseudotumoral mass. A, FLAIR-weighted images show enlargement and hyperintensity of the head of the right caudate nucleus.
Images from the case of an 8-year-old female patient with complex I mitochondrial disease, which was diagnosed when the patient was older than 3 years.
Case 2. Case 2. Selected proton MR spectra (PRESS, 1500/136/1; nominal voxel size, 2 cm3) from the voxels indicated on the scout spin-echo T2-weighted.
Low-grade astrocytoma and anaplastic astrocytoma.
Presentation transcript:

A. di Gaeta, A.A. Diano, P. Vassallo, E. Capobianco, M. Muto Neuroradiology unit A.O.R.N. “A. CARDARELLI” - Napoli Single voxel spectroscopy in the follow-up of low grade gliomas

From january 2003 until november 2009 we studied 24 low-grade astrocytoma with six years follow-up 24 low-grade astrocytoma with six years follow-up  16 hemisferic astrocytoma  2 gliomatosis  2 pylocitic astrocytoma (FCP)  2 trunk glioma  2 well differenziated oligodendrogliomas In 9 lesions we performed hystopathologic analysis surgery in six stereotactic biopsy in three

METHODS sequences sequences for volume sampling -PRESS (point resolved spectroscopy) The most clinically sequence used for its speedy and better S/R ratio(Pattany and all AJNR 27: ,May 2006) technique used “SINGLE VOXEL” (SVS) narrow study field Easily available in the majority of RM systems, rapid acquisition (5min.), but narrow study field even if better than multivoxel (Brandao Lara A. “MR spectroscopy of the brain “ pag ) in posterior fossa,in sovrasellar region and in regionsadjacent to skull base. The decision of which sequences(SVS or multivoxel ) and which parameters ( TE or TR) to use depends on the location of the lesion and the choice of the brain metabolites the investigator wants to evaluate Sundgren P.C. Mr spectroscopy in radiation injury AJNR 30: sep RM magnet 1,5T, “head-coil” square, basic sequences (SE T1, T2 e flair) with and without contrast Standard RM spectroscopy

SPECTROSCOPIC DATA EVALUATION Spectrum visual analysis (peak height) Ratio NAA (marker neuronal integrity)/Cho ( increase in high grade tumors) Ratio NAA/Cr (reduced in high grade tumors ) Ratio Cho/Cr (increase in high grade tumors) Lactate and lipids evidence (ratio Lactate/Cr) Intermediate echo time (135) ideal to evaluate lactate and choline peaks (Brandao Lara A “MR Spectroscopy of the brain” pag 5,2002 Lippincott)

SPECTROSCOPIC DATA EVALUATION NAA/Cho = 1,8831 NAA/Cr = 1,7935 Cho/Cr = 0,9523

ASTROCITOMA “LOW-GRADE spectrum example” Case 31 R.M., femm a.28 NAA/Cho = 0,4525 NAA/Cr = 0,5023 Cho/Cr = 1,6574

Evaluation criteria Ratio NAA/Cho Lip/Lac peak remarks more than 20% variations in comparition to first examination Appearing or increase in comparition to first examination To remember that low grade gliomas spectrum could be similar to normal parenchyma (Brandao Lara A. pag 142 ;2002) Only in cases not treated

 Doesnt exist a real cut-off value of NAA/Cho ratio (Cha AJNR 27: , March 2006).Indeed it is possible only differenziate tumour lesion from pseudotumoral lesion. (Majos “Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses AJNR 30: , March 2009) that is % diagnostic accuracy  we have not evaluated lipids and lactate in treated gliomas because their values are always elevated and don’t show a good correlation with histologic grade of the lesion.  Lipids are present almost exclusively in high grade gliomas whereas lactate could be found in both low grade and  high grade gliomas. (Xiaojuan Li AJNR 26: , April 2005) PRELIMINAR GENERAL CONSIDERATIONS

The use of NAA/Cho ratio allowed a correct retrospective classification in 80% of the cases in differenziating recurrent tumour from radiation injury with SVS(single Voxel spectroscopy) Schlemmer HP,Bachert P, Herfarth K Proton Mr spectroscopic evaluation of suspicious brain lesion after stereotactic radiotherapy AJNR 2001;22 : The most effective method of spectrum evaluation in SVS is the NAA/ Cho ratio. MR Spectroscopy in radiation injury Sundgren P.C.AJNR 30: september 2009

 A correlative study between spettroscopy and perfusion(CBF) show a good care sampling of the metabolites in more hyperfused areas ( higher Cho and increased lipids-lactate/creatina ratio ) in the high grade lesions in comparition to low grade lesions. (Chawla AJNR 28: , October 2007)  Also a MET– PET correlative study has shown a good reliability showing the turn over a more aggressive behaviour ( metionina high uptake) in comparision to a more quiescent behaviour (low uptake). (Kato “Analysis of C-methionine uptake in low-grade gliomas and correlation with proliferative activity” AJNR 29 : , 2007)  Morever has been demonstrated that the low TE (30) myoinositol sampling has shown a remarkable accuracy in discerning low grade gliomas (high MI/Cr ratio )from high grade gliomas(MI/Cr low ratio) (Castillo M AJNR 21: , 2000) RELATED PAPERS OF TURNING OF LOW GRADE LESIONS TO HIGH GRADE LESIONS  A good correlation of trasformation from grade 2 gliomas to grade 3 anaplastic astrocytoma was found monitoring a gradual increase of the choline and the creatine (Majos Eur Radiology 13(3): , March 2003)

Some examples

6° 30 months later 6° examination 17/03/ months later 4° 4° spectroscopic examination 13/05/2005 NAA/Cho = 0,3876 NAA/Cr = 0,6070 Cho/Cr = 1,5495 NAA/Cho = 0,2764 NAA/Cr = 0,5208 Cho/Cr = 1,883 NAA/Cho = 0,1414 NAA/Cr = 0,2873 Cho/Cr = 2, spectroscopic examination 01/09/2003 TE 135 TE 35 TE 135

3a. e 10m.after 1°examination 4° examination - 29/12/2006 – 3a. e 10m.after 1°examination NAA/Cho = 0,0871 NAA/Cr = 0,2626 Cho/Cr = 3,0188 NAA/Cho = 0,1535 NAA/Cr = 0,4509 Cho/Cr = 2,3057 1° 1° spectroscopic examination - 16/02/2003 NAA/Cho > 20%

1° examination - 19/01/2006 NAA/Cho = 0,8306 NAA/Cr = 0,8127 Cho/Cr = 0,9705 4° esame - 26/02/2007 – 13 months after first examination NAA/Cho = 0,6491 NAA/Cr = 0,6968 Cho/Cr = 1,0733

“LOW-GRADE” astrocytoma spectroscopic follow-up Case N.95. S.G. 30 a. 1° examination january 2005 CT performed for seizure after minor trauma ( face injury playing soccer)

june ° examination (six months later). june RM spectroscopy NAA/Cho = 0,4538 NAA/Cr = 0,8505 Cho/Cr = 1,8741 “LOW-GRADE” ASTROCYTOMA SPECTROSCOPIC FOLLOW’UP

“LOW-GRADE”astrocytoma spectroscopic follow-up 3° examination ( 4 months later) October 2005 NAA/Cho = 0,1999 NAA/Cr = 0,4130 Cho/Cr = 2,0656

2months later 4° examination 2months later (december 2005) NAA/Cho = 0,4680 NAA/Cr = 0,8297 Cho/Cr = 1,7726 NAA/Cho = 0,3522 NAA/Cr = 0,7553 Cho/Cr = 2,1445

NAA/Cho = 0,2511 NAA/Cr = 0,5712 Cho/Cr = 2,2747 months later (March 2006). Voxel positioned at the core lesion 5° examination 3 months later (March 2006). Voxel positioned at the core lesion ASTROCITOMA “LOW-GRADE”spectroscopy follow-up

NAA/Cho = 0,4538 NAA/Cr = 0,8505 Cho/Cr = 1,8741 NAA/Cho = 0,2511 NAA/Cr = 0,5712 Cho/Cr = 2,2747 june ° spectroscopic examination june months later (March 2006) 4° spectroscopic examination 9 months later (March 2006) NAA/Cho > 20% Lip

FUNCTIONAL MRI” april 2006

surgery Hystologic data : Macroscopic report: “fragments of whitish, homogenous… tissue ” Microscopic report : “glial tumour fairly cellular, mainly microcistic, composed by monomorfe cells, ” Diagnosis: Oligoastrocitoma (grado II WHO)

january ° spectroscopic control after surgery. january 2007

2007 2° spectroscopic control after surgery. April 2007

2009 3° spectroscopic control after surgery. April 2009

2009 4° spectroscopic control after surgery. Nov 2009

OLIGODENDROGLIOMA spectroscopy follow-up 1° Case 106. D’A.G. A. 43 women. Operated 4 years before : “oligondendroglioma well differenziated” 1° spectroscopic examination 05/01/2006 NAA/Cho = 0,1551 NAA/Cr = 0,3696 Cho/Cr = 2,3825

OLIGODENDROGLIOMA spectroscopy follow-up 2°5 2° spectroscopic examination 12/05/ months later NAA/Cho = 0,2320 NAA/Cr = 0,5166 Cho/Cr = 2,2263

OLIGODENDROGLIOMA spectroscopy follow-up 3° 3°spectroscopic examination 16/01/ months.later 1 year after 1° spectrum NAA/Cho = 0,2047 NAA/Cr = 0,6040 Cho/Cr = 2,9497

NAA/Cho = 0,1551 NAA/Cr = 0,3696 Cho/Cr = 2,3825 NAA/Cho = 0,2320 NAA/Cr = 0,5166 Cho/Cr = 2,2263 1° 1° MRs 05/01/2006 2° 2° MRs 5 months later 3° 3° MRs 1 year later NAA/Cho = 0,2047 NAA/Cr = 0,6040 Cho/Cr = 2,9497

4°1 4°examination 18/06/ months later 2 years and half from 1 spectrum OLIGODENDROGLIOMA spectroscopy follow-up

5°3 5°examination 30/09/ months later2 years and half from 1° spectrum OLIGODENDROGLIOMA spectroscopy follow-up

Results  In 20 patients good correlation between variation of NAA/Cho ratio and appearing or increase of lipid/lactate peaks and clinical-morfologic pattern (stable or progressive)  In 4 hemisferic operated astrocytomas and in a trunk glioma irradiated: disagreement between clinical-morphological pattern (in stable resolution) and spectroscopic pattern (persistent inversion of the NAA/Cho e Cho/Cr ratio)  In 2 of these patients restart of the disease at the subsequent controls  The appearing of a spectroscopic alteration could anticipate of about 1-2months contrast enhancment with standard RM(Brandao Lara A. “MR Spectroscopy of the Brain” pag 158. Lippincott)

Conclusions 2 are the more interesting clinical applications of the spectroscopic SVS follow-up of the brain neoplasm not operated lesions turn“surveallance” of the not operated lesions and possibility of evaluate an initial “turn ” from “low- grade” to high grade lesions. evaluation after surgery and sometimes after RT of the beginning of the neoplastic relapse But the effort to separate tumor recurrence from pure radiation damage might be more problematic when using SVS compared with using multivoxel spectroscopy.Sundgren P.C. Mr spectroscopy in radiation injury AJNR 30: September 2009

Thank you